FatiAbGen Inc. Alternatives & Competitors
12 companies similar to FatiAbGen Inc. — Best in class multi-modality antibodies for difficult targets in high unmet need...
Companies similar to FatiAbGen Inc.
Iksuda Therapeutics
Creating class-leading ADCs with enhanced tumor specificity
Newcastle Upon Tyne, Unit...
Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...
San Diego, United States
ADC Therapeutics
Innovating Science. Inspiring Hope.
Lausanne, Switzerland
Pyxis Oncology
Charting a course to therapeutics for difficult-to-treat cancer.
Boston, United States
Track all FatiAbGen Inc. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Alchemab Therapeutics Ltd
Pioneering Patient-led Antibody Therapeutics
London, United Kingdom
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
Anodyne Nanotech, Inc
Simplifying Chronic Care
Boston, United States
Umoja Biopharma
Pioneering advanced immunotherapies to empower the body's innate ability to fight cancer b...
Bolt Biotherapeutics, Inc.
Plans to develop a novel format for T-cell mediated anti-tumour therapy
Redwood City, United Stat...
Onchilles Pharma
Developing drug candidates that have the potential to be broadly effective against a wide...
San Diego, United States
Mythic Therapeutics, Inc.
Charting a new dimension in ADC technology
Waltham, United States
Genmab
Differentiated human antibody therapeutics for the treatment of cancer
Denmark
About FatiAbGen Inc.
FatiAbGen Inc., founded in 2020, is an innovative player in the Biopharma, Biotechnology, and Pharmaceutical industries. The company's slogan, "Best in class multi-modality antibodies for difficult targets in high unmet need diseases in oncology and immunology," highlights its commitment to developing advanced therapie...
Antibody Drug Development, Research in Oncology and Immunology, Joint R&D Collaborations
Healthcare Providers, Biotech Firms, Pharmaceutical Companies, Academic and Research Institutions
Multi-modality Antibodies, Oncology Therapeutics, Immunology Therapeutics, Antibody Engineering, Biotech Collaboration, Shonan IPark, JLABS Member, Pre-clinical Pipeline, Antibody-drug Conjugates, Bi-specific Antibodies, CAR-T Technology, Mesothelin Targeting, Solid Tumor Treatment, MSLN ADC, IgE Therapies
B2B, B2B2B
Licensing, Project Based, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches FatiAbGen Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at FatiAbGen Inc. on 12 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 25 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
